Mice lacking uteroglobin are highly susceptible to developing pulmonary fibrosis

FEBS Letters

Volumn 580, Issue 18, 2006, Pages 4515-4520

  Lee, Yi Ching ^a   Zhang, Zhongjian ^a   Mukherjee, Anil B ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Chemotaxis; Inflammation; Pulmonary fibrosis; Uteroglobin

Indexed keywords

BLEOMYCIN; CYTOKINE; TRANSFORMING GROWTH FACTOR BETA; UTEROGLOBIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HELPER CELL; HOMEOSTASIS; LUNG FIBROSIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION;

ANIMALS; BIOLOGICAL MARKERS; BLEOMYCIN; CYTOKINES; LUNG; MICE; MICE, KNOCKOUT; PNEUMONIA; PULMONARY FIBROSIS; SURVIVAL ANALYSIS; TH2 CELLS; UTEROGLOBIN;

MAMMALIA;

EID: 33746509707     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.07.031     Document Type: Article

References (24)

1. Mukherjee A.B., and Chilton B.S. The Uteroglobin/Clara cell protein family. Ann. N.Y. Acad. Sci. 923 (2000) 348-354
2. Mukherjee A.B., Kundu G.C., Mantile-Selvaggi G., Yuan C.J., Mandal A.K., Chattopadhyay S., Zheng F., Pattabiraman N., and Zhang Z. Uteroglobin: a novel cytokine?. Cell Mol. Life Sci. 55 (1999) 771-787
3. Hewetson A., Hendrix E.C., Mansharamani M., Lee V.H., and Chilton B.S. Identification of the RUSH consensus-binding site by cyclic amplification and selection of targets: demonstration that RUSH mediates the ability of prolactin to augment progesterone-dependent gene expression. Mol. Endocrinol. 16 (2002) 2101-2112
4. Zhang Z., Kundu G.C., Yuan C.J., Ward J.M., Lee E.J., DeMayo F., Westphal H., and Mukherjee A.B. Severe fibronectin-deposit renal glomerular disease in mice lacking uteroglobin. Science 276 (1997) 1408-1412
5. Wynn T.A. Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat. Rev. Immunol. 4 (2004) 583-594
6. Coultas D.B., Zumwalt R.E., Black W.C., and Sobonya R.E. The epidemiology of interstitial lung diseases. Am. J. Respir. Crit. Care Med. 150 (1994) 967-972
7. Adamson I.Y. Drug-induced pulmonary fibrosis. Environ. Health Perspect. 55 (1984) 25-36
8. Mandal A.K., Zhang Z., Ray R., Choi M.S., Chowdhury B., Pattabiraman N., and Mukherjee A.B. Uteroglobin represses allergen-induced inflammatory response by blocking PGD2 receptor-mediated functions. J. Exp. Med. 199 (2004) 1317-1330
9. Chen L.C., Zhang Z., Myers A.C., and Huang S.K. Cutting edge: altered pulmonary eosinophilic inflammation in mice deficient for Clara cell secretory 10-kDa protein. J. Immunol. 167 (2001) 3025-3028
10. Hattori N., Degen J.L., Sisson T.H., Liu H., Moore B.B., Pandrangi R.G., Simon R.H., and Drew A.F. Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice. J. Clin. Invest. 106 (2000) 1341-1350
11. Lee C.G., Homer R.J., Zhu Z., Lanone S., Wang X., Koteliansky V., Shipley J.M., Gotwals P., Noble P., Chen Q., et al. Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). J. Exp. Med. 194 (2001) 809-821
12. Belperio J.A., Dy M., Murray L., Burdick M.D., Xue Y.Y., Strieter R.M., and Keane M.P. The role of the Th2 CC chemokine ligand CCL17 in pulmonary fibrosis. J. Immunol. 173 (2004) 4692-4698
13. Barnes P.J. Cytokine modulators for allergic diseases. Curr. Opin. Allergy Clin. Immunol. 1 (2001) 555-560
14. Down J.D., and Steel G.G. The expression of early and late damage after thoracic irradiation: a comparison between CBA and C57B1 mice. Radiat. Res. 96 (1983) 603-610
15. Rossi G.A., Szapiel S., Ferrans V.J., and Crystal R.G. Susceptibility to experimental interstitial lung disease is modified by immune- and non-immune-related genes. Am. Rev. Respir. Dis. 135 (1987) 448-455
16. Ward W.F., Sharplin J., Franko A.J., and Hinz J.M. Radiation-induced pulmonary endothelial dysfunction and hydroxyproline accumulation in four strains of mice. Radiat. Res. 120 (1989) 113-120
17. Daly H.E., Baecher-Allan C.M., Barth R.K., D'Angio C.T., and Finkelstein J.N. Bleomycin induces strain-dependent alterations in the pattern of epithelial cell-specific marker expression in mouse lung. Toxicol. Appl. Pharmacol. 142 (1997) 303-310
18. Schrier D.J., Kunkel R.G., and Phan S.H. The role of strain variation in murine bleomycin-induced pulmonary fibrosis. Am. Rev. Respir. Dis. 127 (1983) 63-66
19. Vasanthakumar G., Manjunath R., Mukherjee A.B., Warabi H., and Schiffmann E. Inhibition of phagocyte chemotaxis by uteroglobin, an inhibitor of blastocyst rejection. Biochem. Pharmacol. 37 (1988) 389-394
20. Chapman H.A. Disorders of lung matrix remodeling. J. Clin. Invest. 113 (2004) 148-157
21. Zhu Z., Homer R.J., Wang Z., Chen Q., Geba G.P., Wang J., Zhang Y., and Elias J.A. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J. Clin. Invest. 103 (1999) 779-788
22. Lopez de Haro M.S., Perez Martinez M., Garcia C., and Nieto A. Binding of retinoids to uteroglobin. FEBS Lett. 349 (1994) 249-251
23. Kundu G.C., Mandal A.K., Zhang Z., Mantile-Selvaggi G., and Mukherjee A.B. Uteroglobin (UG) suppresses extracellular matrix invasion by normal and cancer cells that express the high affinity UG-binding proteins. J. Biol. Chem. 273 (1998) 22819-22824
24. Zhang Z., Kim S.J., Chowdhury B., Wang J., Lee Y.C., Tsai P.C., Choi M., and Mukherjee A.B. Interaction of uteroglobin with lipocalin-1 receptor suppresses cancer cell motility and invasion. Gene 369 (2006) 66-71